Medizinische Universität Graz - Research portal
-
Assoz. Prof.in Priv.-Doz.in Mag.a Dr.in rer.nat. Nadia Dandachi
- Division of Oncology
- Head of Research Unit
- Epigenetische und genetische Tumorbiomarker
- EMail: nadia.dandachi(at)medunigraz.at
- Tel: +43/316/385/80624
- http://www.onkologie-graz.at
- MEDonline-Visitenkarte
- Externe ID's
- ORCiD: 0000-0001-9093-0743
Statistik Austria, science classification
- Genetics - (106013)
- Molecular biology - (106023)
- Medical biology - (301304)
- Cancer research - (301904)
- Oncology - (302055)
Scientific Expertise
- DNA methylation
- mutation detection
- Circulating Tumor Cells
- Cancer Stem Cells
- Cancer biomarkers
- tumor heterogeneity
- primary cell culture
Curr. Vitae
| 2013 | Associated Professor, Division of Oncology, Department of Internal Medicine, Medical University Graz, Austria |
| 2013 | Head of the research unit epigenetic and genetic cancer biomarkers |
| 2012 | Assistent Professor, Division of Oncology, Department of Internal Medicine, Medical University of Graz |
| 2012 -2013 | Postdoctoral fellow at the McMaster Stem Cell and Cancer Research Institute (Singh Lab), McMaster University, Canada |
| 2009 | Venia docendi in Pathophysiology and Immunology |
| 2002 | Reserach Molecular Biologist and Supervisor of the Research Laboratory at the Clinical Department of Oncology, Medical University Graz (Head: Univ.-Prof. Dr. H. Samonigg) |
| 2001 -2002 | Molecular biologist and scientific supervisor of the laboratory for immunohistological and molecular biological research |
| 1998 -2001 | PhD study of Genetics at the Paris-Lodron University Salzburg and Doctoral thesis Her-2/neu oncogene in breast cancer at the Institute of Pathology, Landeskliniken Salzburg (Supervisor Univ.-Doz. Dr. C. Hauser-Kronberger) |
| 1991 -1998 | Study of Biology at the Paris-Lodron University Salzburg and Diploma thesis Tenascin-C and Vimentin in human breast carcinoma at the Institute of Pathology, Landeskliniken Salzburg (Supervisor Univ.-Doz. Dr. C. Hauser-Kronberger) in cooperation with the Austrian Academy of Sciences, Institute of Molecular Biology, Salzburg |
Reviewer for scientific journals
| 2022 -2022 | CANCER CELL |
| 2022 -2022 | EBIOMEDICINE |
| 2020 -2020 | CANCER LETTERS |
| 2014 -2018 | CANCER LETTERS |
| 2015 -2018 | BMC CANCER |
| 2016 -2018 | BRITISH JOURNAL OF CANCER |
| 2016 -2018 | JOURNAL OF MOLECULAR DIAGNOSTICS |
| 2016 -2018 | NUCLEIC ACIDS RESEARCH |
| 2016 -2018 | ONCOTARGET |
| 2018 -2018 | MODERN PATHOLOGY |
| 2014 -2015 | TUMOUR BIOLOGY |
| 2013 -2014 | BMC CANCER |
| 2014 -2014 | BMC CANCER |
| 2014 -2014 | BREAST CANCER RESEARCH |
| 2008 -2013 | CLINICAL BIOCHEMISTRY |
| 2008 -2013 | NUCLEIC ACIDS RESEARCH |
| 2011 -2012 | CANCER LETTERS |
| 2011 -2012 | JOURNAL OF MOLECULAR DIAGNOSTICS |
| 2012 -2012 | JOURNAL OF MOLECULAR DIAGNOSTICS |
| 2011 -2011 | BREAST CANCER RESEARCH AND TREATMENT |
| 2011 -2011 | CLINICAL COLORECTAL CANCER |
| 2009 -2009 | BMC CANCER |
| 2009 -2009 | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE |
| 2006 -2007 | CLINICAL CHEMISTRY |
| 2007 -2007 | GYNECOLOGIC ONCOLOGY |
| 2004 -2005 | BREAST CANCER RESEARCH |
| 2003 -2004 | JOURNAL OF CLINICAL PATHOLOGY |
Reviewer/Expert funding organizations
| 2020 -2021 | Dutch Cancer Society - Netherlands |
| 2020 -2020 | Jubiläumsfond der Österr. Nationalbank, Österreich - Austria |
| 2019 -2019 | Jubiläumsfond der Österr. Nationalbank, Österreich - Austria |
| 2019 -2019 | National Science Centre - Poland |
| 2014 -2016 | Jubiläumsfond der Österreichischen Nationalbank - Austria |
| 2016 -2016 | Hans und Blanca Moser-Stiftung - Austria |
| 2010 -2013 | Jubiläumsfonds der Österreichischen Nationalbank (ÖNB) - Austria |
| 2011 -2013 | PMU-FFF, Paracelsus Medical University Research Fund - Austria |